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Gynura procumbens, a tropical herbaceous
shrub locally known as “Sambung Nyawa”, is
ubiquitously distributed in Southeast Asia and
traditionally used as remedy for fever, inflammation,
hypertension and diabetes (Perry 1980). The
scientific basis for some of these claims including
anti-inflammatory (Iskander et al., 2002), anti-
hypertensive (Hoe et al., 2011) and anti-
hyperglycaemic (Algariri et al., 2013) properties
have been evaluated. Amongst these, the anti-
hyperglycaemic activity of G. procumbens has been
extensively investigated (Hassan et al., 2010; Chong
et al., 2012; Algariri et al., 2013). One of the
phytoconstituents of G. procumbens, kaempferol has
been reported to exhibit glucose-lowering effects in
soleus muscle mediated through PI3K/Akt pathway
(Cazarolli et al., 2009). In addition, kaempferol has
been shown to protect pancreatic beta-cells from
hyperglycaemia-induced apoptosis and dysfunction
(Zhang & Liu 2011) as well as to exhibit anti-
oxidant effects (Choi 2011) through activation of
Akt. A critical downstream component of PI3K/Akt
pathway in insulin signaling and control of
glycogen metabolism is glycogen synthase kinase-
3β (GSK3β).
GSK3, a serine/threonine kinase initially
identified by Embi et al. (1980) is constitutively
active under basal conditions and is phosphorylated
and inhibited by Akt during insulin stimulation
(Cross et al., 1995). The kinase is now recognised
to be involved in the regulation of a multitude of
cellular functions such as protein synthesis,
regulation of transcription factors, proliferation,
apoptosis and inflammatory response to infections.
Dysregulation of GSK3 activity is implicated in a
diverse array of human pathologies including Type
2 diabetes, Alzheimer’s disease and cancer (Wang
et al., 2014). Our previous findings indicate that the
anti-hyperglycaemic effects of G. procumbens
fractions in streptozotocin-induced diabetic rats
involved increased phosphorylation of liver GSK3β
(Ser9) (Chong et al., 2012). Here, we postulate that
the anti-hyperglycaemic effect of G. procumbens
involving inhibition of GSK3β is mediated by
kaempferol. Therefore the present study aims to
evaluate whether the anti-hyperglycaemic effects of
G. procumbens aqueous extract and kaempferol each
involve phosphorylation of GSK3β.
Our results revealed that G. procumbens,
kaempferol, and metformin each improved glucose
consumption of hyperglycaemic HepG2 cells in a
concentration dependent-manner (Figure 1). At
a concentration of 0.1 μg/mL, G. procumbens,
kaempferol and metformin each increased glucose
consumption by 51%, 81.5% and 86.3%
respectively. Increased phosphorylations of GSK3β
(Ser9) were detected in both G. procumbens- and
kaempferol-treated HepG2 cells by 22.56- and 2.50-
fold respectively as compared to non-treated control.
Phosphorylated GSK3β was not detected in cells
cultured in low or high glucose media in the absence
of test extract or compound (Figure 2). This strongly
suggests that the anti-hyperglycaemic activity of G.
procumbens and kaempferol each is mediated
through phosphorylation and inhibition of GSK3β.
Involvement of GSK3β in insulin signaling
pathway is well-documented. In normal glucose
metabolism, insulin receptor activation leads to
phosphorylation and activation of Akt and
consequently inhibition of GSK3β (Gao et al.,
2011). In type 2 diabetic mice, phosphorylation
of GSK3β (Ser9) was significantly lower than
normal mice indicating over-activity of GSK3
under diabetic conditions (Henriksen & Dokken
2006). Pharmacological inhibitors of GSK3 have
been reported to improve glucose uptake in
hyperglycaemic cell cultures and in insulin-resistant
rat skeletal muscle (Meijer et al., 2004; Wagman et
al., 2004). Our current findings showed that
treatment of hyperglycaemic HepG2 cells with
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Fig. 1. Dose-effect of glucose consumption in HepG2 cells treated with or without
G. procumbens aqueous extract, kaempferol or metformin at different
concentrations for 24 hours. The glucose concentration remaining in suspension
was measured and normalised to cell number. Data presented as mean ± S.D.
aqueous extract of G. procumbens resulted in
increased glucose uptake as well as increased
phosphorylation of GSK3β. Similarly, treatment
with kaempferol also resulted in improved glucose
uptake and increased levels of pGSK3β.
It is noteworthy that phytochemical analysis of
G. procumbens extracts identified rutin (quercetin-
3-O-rutinoside), quercetin (kaempferol-3-o-
rutinoside), astragalin (kaempferol-3-glucoside) and
kaempferol as components (Hassan et al., 2010).
These phytoconstituents have been implicated in
the blood glucose-lowering activity of the plant and
reported to mimic or improve insulin action at the
cellular level (Hassan et al., 2010). In addition,
kaempferol 3-neohesperidoside has been reported to
show insulin-like properties in glucose lowering in
rat soleus muscle via a mechanism involving
inhibition of GSK3β through PI3K-GSK3 pathway
(Cazarolli et al., 2009). To our knowledge, the anti-
hyperglycaemic effect of kaempferol in HepG2 cells
observed in the present study has not been reported
previously. Our findings suggest that the
biochemical basis of the anti-hyperglycaemic effect
observed in G. procumbens aqueous extract is in
part attributed to inhibition of GSK3β elicited by
kaempferol. In conclusion, the present study
provides scientific evidence for the documented
traditional use of G. procumbens to treat diabetes.
Our findings offer a possible explanation for the
many insulinomimetic effects of G. procumbens
reported by previous investigators. As such, GSK3,
as an important component in insulin signaling, is
a plausible drug target for development of
therapeutics against diabetes.
Fig. 2. Fold-change of GSK3β phosphorylation levels in low glucose (LG) or high glucose (HG) HepG2 cells with incubation
of metformin (Metf), G. procumbens (Gp) or kaempferol (Kf). Each sample was extracted 24 hours after respective treatment.
Levels of phospho-GSK3β (Ser9) were normalised to total levels of GSK3β. Data presented as mean ± S.D.
GSK3β INHIBITION BY KAEMPFEROL MEDIATES THE ANTI-HYPERGLYCAEMIC 145
ACKNOWLEDGEMENTS
This work was supported by research grants from the
Institute of Pharmaceuticals and Nutraceuticals
Malaysia, Ministry of Science, Technology and
Innovation (09-05-IFN-BPH-001).
REFERENCES
Algariri, K., Kuong, Y.M., Atangwho, I.J., Asmawi,
M.Z., Sadikun, A., Murugaiyah, V. & Ismail, N.
2013. Hypoglycemic and anti-hyperglycemic
study of Gynura procumbens leaf extracts. Asian
Pacific Journal of Tropical Biomedicine 3(5):
974-981.
Cazarolli, L.H., Folador, P., Pizzolatti, M.G. & Mena
Barreto Silva, F.R. 2009. Signaling pathways of
kaempferol-3-neohesperidoside in glycogen
synthesis in rat soleus muscle. Biochimie 91(7):
843-849.
Choi, E.M. 2011. Kaempferol protects MC3T3-E1
cells through antioxidant effect and regulation
of mitochondrial function. Food and Chemical
Toxicology 49(8): 1800-1805.
Chong, C.J., Lee, H.W., Halimah, A.S., Jalifah, L.,
Jualang, A.G., Lee, P.C., Embi, N. & Hasidah,
M.S. 2012. Hypoglycemic effects of Gynura
procumbens fraction on streptozotocin-induced
diabetic rats involved phosphorylation of
GSK3β (Ser-9) in liver. Sains Malaysiana 41(8):
969-975.
Cross, D.A., Alessi, D.R., Cohen, P., Andjelkovich,
M. & Hemmings, B.A. 1995. Inhibition of
glycogen synthase kinase-3 by insulin mediated
by protein kinase B. Nature 378(6559): 785-
789.
Embi, N., Rylatt, D.B. & Cohen, P. 1980. Glycogen
synthase kinase-3 from rabbit skeletal muscle.
Separation from cyclic-AMP-dependent protein
kinase and phosphorylase kinase. European
Journal of Biochemistry 107(2): 519-527.
Gao, C., Hölscher, C., Liu, Y. & Li, L. 2011.
GSK3: a key target for the development of
novel treatments for type 2 diabetes mellitus
and Alzheimer disease. Annual Reviews
Neuroscience 23(1): 1-11.
Hassan, Z., Yam, M.F., Mariam, A. & Ahmad Pauzi,
M.Y. 2010. Antidiabetic properties and
mechanism of action of Gynura procumbens
water extract in streptozotocin-induced diabetic
rats. Molecules 15(12): 9008-9023.
Henriksen, E.J. & Dokken, B.B. 2006. Role of
glycogen synthase kinase-3 in insulin resistance
and type 2 diabetes. Current Drug Targets
7(11): 1435-1441.
Hoe, S.Z., Lee, C.N., Mok, S.L., Kamaruddin, M.Y.
& Lam, S.K. 2011. Gynura procumbens Merr.
decreases blood pressure in rats by
vasodilatation via inhibition of calcium
channels. Clinics 66(1): 143-150.
Iskander, M.N., Song, Y., Coupar, I.M. &
Jiratchariyakul, W., 2002. Antiinflammatory
screening of the medicinal plant Gynura
procumbens. Plant Foods for Human Nutrition
57(3-4): 233-244.
Meijer, L., Flajolet, M. & Greengard, P. 2004.
Pharmacological inhibitors of glycogen
synthase kinase 3. Trends in Pharmacological
Sciences 25(9): 471-480.
Perry, L.M. 1980. Medical Plants of East and
Southeast Asia: Attributed Properties and Uses.
Cambridge: The MIT Press. p. 632.
Wagman, A.S., Johnson, K.W. & Bussiere, D.E. 2004.
Discovery and development of GSK3 inhibitors
for the treatment of type 2 diabetes. Current
Pharmaceutical Design 10(10): 1105-1137.
Wang, H., Kumar, A., Lamont, R.J. & Scott, D.A.
2014. GSK3β and the control of infectious
bacterial diseases. Trends in Microbiology
22(4): 208-217.
Zhang, Y. & Liu, D. 2011. Flavonol kaempferol
improves chronic hyperglycemia-impaired
pancreatic beta-cell viability and insulin
secretory function. European Journal of
Pharmacology 670(1): 325-332.

